These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment. Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398 [TBL] [Abstract][Full Text] [Related]
5. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells. Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195 [TBL] [Abstract][Full Text] [Related]
6. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681 [TBL] [Abstract][Full Text] [Related]
7. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078 [TBL] [Abstract][Full Text] [Related]
8. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis. Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715 [TBL] [Abstract][Full Text] [Related]
9. PHGDH as a mechanism for resistance in metabolically-driven cancers. Rathore R; Schutt CR; Van Tine BA Cancer Drug Resist; 2020; 3(4):762-774. PubMed ID: 33511334 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells. Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531 [TBL] [Abstract][Full Text] [Related]
11. Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment? McNamee MJ; Michod D; Niklison-Chirou MV Cell Death Discov; 2021 Apr; 7(1):87. PubMed ID: 33931592 [TBL] [Abstract][Full Text] [Related]
12. A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development. Wang DW; Wu L; Cao Y; Yang L; Liu W; E XQ; Ji G; Bi ZG Cell Signal; 2017 Jan; 29():107-114. PubMed ID: 27297361 [TBL] [Abstract][Full Text] [Related]
13. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. Ou Y; Wang SJ; Jiang L; Zheng B; Gu W J Biol Chem; 2015 Jan; 290(1):457-66. PubMed ID: 25404730 [TBL] [Abstract][Full Text] [Related]
14. Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer. Xian Y; Zhang S; Wang X; Qin J; Wang W; Wu H Onco Targets Ther; 2016; 9():5553-60. PubMed ID: 27660473 [TBL] [Abstract][Full Text] [Related]
15. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity. Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046 [TBL] [Abstract][Full Text] [Related]
16. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. Wu X; Xia J; Zhang J; Zhu Y; Wu Y; Guo J; Chen S; Lei Q; Meng B; Kuang C; Feng X; He Y; Shen Y; Li X; Qiu L; Li G; Zhou W Br J Haematol; 2020 Jul; 190(1):52-66. PubMed ID: 32037523 [TBL] [Abstract][Full Text] [Related]
17. The NAD Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3. Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555 [TBL] [Abstract][Full Text] [Related]
19. Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism. Reid MA; Allen AE; Liu S; Liberti MV; Liu P; Liu X; Dai Z; Gao X; Wang Q; Liu Y; Lai L; Locasale JW Nat Commun; 2018 Dec; 9(1):5442. PubMed ID: 30575741 [TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis. Wang X; Lai P; Zhang Z; Huang M; Wang L; Yin M; Jin D; Zhou R; Bai X Oncol Rep; 2014 Jul; 32(1):382-8. PubMed ID: 24840134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]